Corient Private Wealth LLC Buys New Stake in Privia Health Group, Inc. (NASDAQ:PRVA)

Corient Private Wealth LLC purchased a new stake in Privia Health Group, Inc. (NASDAQ:PRVA) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 68,821 shares of the company’s stock, valued at approximately $1,345,000. Corient Private Wealth LLC owned about 0.06% of Privia Health Group at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Park Avenue Securities LLC lifted its holdings in shares of Privia Health Group by 3.8% in the 4th quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after purchasing an additional 532 shares during the last quarter. PNC Financial Services Group Inc. increased its position in Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock worth $140,000 after buying an additional 533 shares during the period. First Horizon Advisors Inc. lifted its stake in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after buying an additional 632 shares during the last quarter. HighTower Advisors LLC boosted its holdings in shares of Privia Health Group by 5.0% in the fourth quarter. HighTower Advisors LLC now owns 19,469 shares of the company’s stock valued at $381,000 after acquiring an additional 932 shares during the period. Finally, US Bancorp DE grew its position in shares of Privia Health Group by 6.7% during the fourth quarter. US Bancorp DE now owns 18,058 shares of the company’s stock worth $353,000 after acquiring an additional 1,134 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Stock Down 4.9 %

NASDAQ:PRVA opened at $22.75 on Wednesday. The firm’s fifty day simple moving average is $23.75 and its 200-day simple moving average is $21.11. The stock has a market cap of $2.74 billion, a PE ratio of 227.52, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $26.04.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Canaccord Genuity Group upped their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. Macquarie initiated coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 target price for the company. JPMorgan Chase & Co. raised their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Needham & Company LLC reaffirmed a “buy” rating and set a $30.00 price objective on shares of Privia Health Group in a research note on Friday, March 21st. Finally, JMP Securities set a $29.00 target price on Privia Health Group in a research note on Friday, February 28th. One research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, Privia Health Group has a consensus rating of “Buy” and an average target price of $26.67.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.